Efficient chemokine-dependent migration and primary and secondary IL-12 secretion by human dendritic cells stimulated through Toll-like receptors - PubMed (original) (raw)
Efficient chemokine-dependent migration and primary and secondary IL-12 secretion by human dendritic cells stimulated through Toll-like receptors
Manfred Lehner et al. J Immunother. 2007 Apr.
Abstract
Recent findings have demonstrated the properties of cell migration and cytokine secretion to be mutually exclusive and linked them to different functional subpopulations of dendritic cells (DCs). We studied human monocyte-derived DCs after stimulation with peptidoglycan (PGN), poly(I:C), lipopolysaccharide (LPS), and R848 (resiquimod) and found the resulting mature DCs to express CCR7, to migrate toward CCL19 and to be efficient primary interleukin (IL)-12 producers. Importantly, the potential for secondary production of large amounts of IL-12p70 in response to CD40 ligation was also preserved after stimulation by all Toll-like receptor (TLR) ligands. Differences between the TLR ligands were seen in the primary secretion of IL-12 and IL-23, in the survival of the DCs and in the expression of CD38. Finally, DCs stimulated by R848 were efficient in expanding peptide-specific CD8-positive T cells capable of peptide-specific target cell lysis. Together, our data suggest that TLR ligands induce the generation of mature DCs that integrate migratory and cytokine secretory capacity as well as cytotoxic T lymphocyte (CTL) stimulatory properties.
Similar articles
- Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses.
Bohnenkamp HR, Papazisis KT, Burchell JM, Taylor-Papadimitriou J. Bohnenkamp HR, et al. Cell Immunol. 2007 Jun;247(2):72-84. doi: 10.1016/j.cellimm.2007.07.008. Epub 2007 Oct 24. Cell Immunol. 2007. PMID: 17927969 - Differential induction of interleukin-10 and interleukin-12 in dendritic cells by microbial toll-like receptor activators and skewing of T-cell cytokine profiles.
Qi H, Denning TL, Soong L. Qi H, et al. Infect Immun. 2003 Jun;71(6):3337-42. doi: 10.1128/IAI.71.6.3337-3342.2003. Infect Immun. 2003. PMID: 12761116 Free PMC article. - Differential production of IL-23 and IL-12 by myeloid-derived dendritic cells in response to TLR agonists.
Roses RE, Xu S, Xu M, Koldovsky U, Koski G, Czerniecki BJ. Roses RE, et al. J Immunol. 2008 Oct 1;181(7):5120-7. doi: 10.4049/jimmunol.181.7.5120. J Immunol. 2008. PMID: 18802116 - Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists.
Nguyen-Pham TN, Lim MS, Nguyen TA, Lee YK, Jin CJ, Lee HJ, Hong CY, Ahn JS, Yang DH, Kim YK, Chung IJ, Park BC, Kim HJ, Lee JJ. Nguyen-Pham TN, et al. Cell Mol Immunol. 2011 Jul;8(4):341-7. doi: 10.1038/cmi.2011.7. Epub 2011 Mar 21. Cell Mol Immunol. 2011. PMID: 21423200 Free PMC article. - Bordetella adenylate cyclase toxin differentially modulates toll-like receptor-stimulated activation, migration and T cell stimulatory capacity of dendritic cells.
Adkins I, Kamanova J, Kocourkova A, Svedova M, Tomala J, Janova H, Masin J, Chladkova B, Bumba L, Kovar M, Ross PJ, Tuckova L, Spisek R, Mills KH, Sebo P. Adkins I, et al. PLoS One. 2014 Aug 1;9(8):e104064. doi: 10.1371/journal.pone.0104064. eCollection 2014. PLoS One. 2014. PMID: 25084094 Free PMC article.
Cited by
- Combination therapy targeting toll like receptors 7, 8 and 9 eliminates large established tumors.
Zhao BG, Vasilakos JP, Tross D, Smirnov D, Klinman DM. Zhao BG, et al. J Immunother Cancer. 2014 May 13;2:12. doi: 10.1186/2051-1426-2-12. eCollection 2014. J Immunother Cancer. 2014. PMID: 24982761 Free PMC article. - Cytokines in Inflammatory Disease.
Kany S, Vollrath JT, Relja B. Kany S, et al. Int J Mol Sci. 2019 Nov 28;20(23):6008. doi: 10.3390/ijms20236008. Int J Mol Sci. 2019. PMID: 31795299 Free PMC article. Review. - Redirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection.
Lehner M, Götz G, Proff J, Schaft N, Dörrie J, Full F, Ensser A, Muller YA, Cerwenka A, Abken H, Parolini O, Ambros PF, Kovar H, Holter W. Lehner M, et al. PLoS One. 2012;7(2):e31210. doi: 10.1371/journal.pone.0031210. Epub 2012 Feb 15. PLoS One. 2012. PMID: 22355347 Free PMC article. - Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.
Anguille S, Smits EL, Cools N, Goossens H, Berneman ZN, Van Tendeloo VF. Anguille S, et al. J Transl Med. 2009 Dec 18;7:109. doi: 10.1186/1479-5876-7-109. J Transl Med. 2009. PMID: 20021667 Free PMC article. - Targeting Toll-like receptor 7/8 enhances uptake of apoptotic leukemic cells by monocyte-derived dendritic cells but interferes with subsequent cytokine-induced maturation.
van den Ancker W, van Luijn MM, Ruben JM, Westers TM, Bontkes HJ, Ossenkoppele GJ, de Gruijl TD, van de Loosdrecht AA. van den Ancker W, et al. Cancer Immunol Immunother. 2011 Jan;60(1):37-47. doi: 10.1007/s00262-010-0917-y. Epub 2010 Sep 22. Cancer Immunol Immunother. 2011. PMID: 20859626 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials